Tempest Announces Private Placement Financing of $15 Million

2 years ago

SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing…

BrainsWay to Report First Quarter Financial Results on May 11, 2022

2 years ago

BURLINGTON, Mass. and JERUSALEM, April 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

Inspire Medical Systems, Inc. to Present at the BofA Securities 2022 Healthcare Conference

2 years ago

MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on…

Caladrius Biosciences and Cend Therapeutics Announce Definitive Merger Agreement

2 years ago

Combined company to be renamed Lisata Therapeutics upon transaction closing Combination will create a financially sound Nasdaq-listed company with a…

Erasca Appoints Jean Liu to its Board of Directors

2 years ago

Ms. Liu, currently chief legal officer at Seagen, brings decades of business and legal experience and will also join Erasca’s…

Oyster Point Pharma to Present New Analyses at the Association for Research in Vision and Ophthalmology (ARVO) 2022

2 years ago

PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on…

GBT to Announce First Quarter 2022 Financial Results on Wednesday, May 4, 2022

2 years ago

SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it…

Simply Better Brands Corp. Announces Execution of Non-Binding Term Sheet to Acquire CFH Limited, a Seed-To-Shelf CBD Manufacturer, to Support Accelerated Growth

2 years ago

Acquisition enables expanded vertical integration, research-driven innovation and cost synergies on the PureKana Wellness BrandVANCOUVER, British Columbia, April 27, 2022…

ContraFect Data Presentations at the 32nd Annual ECCMID Meeting Highlight the Potential of Engineered Lysin CF-370 to Improve Clinical Outcomes and Suppress Antimicrobial Resistance Compared to Antibiotics Alone

2 years ago

Oral Session Demonstrates CF-370’s Potent Activity in a Rabbit Pneumonia Model of an Extensively-Resistant Pseudomonas aeruginosa InfectionYONKERS, N.Y., April 27,…

InnerScope Hearing Technologies (OTC: INND) Launches New eCommerce Website with the Rebranding of iHEAR Direct-to-Consumer Hearing Aids

2 years ago

The New Relaunch of iHEARdirect.com Website Includes: Enhanced Customer FeaturesFree Online Hearing ScreeningHearing Aid & Hearing Loss Information BlogSeries of…